Why is Jenburkt Pharma falling/rising?

As of 19-Sep, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 1,107.55, which reflects a decrease of 14.4 or 1.28%. Today's performance indicates that the stock has underperformed its sector by 1.55%, with an intraday low of Rs 1042, marking a significant drop of 7.13%. The stock's recent returns show a mixed performance; while it has gained 0.82% over the past week, it has a year-to-date decline of 8.82%. The moving averages indicate that the stock is currently higher than its 5-day moving average but lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 105.44% against the 5-day average, suggesting some interest despite the price drop. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
Broader market context shows that while Jenburkt Pharmaceuticals has underperformed the Sensex in the short term, with a 1-month return of 0.78% compared to the Sensex's 1.20%, it has outperformed the benchmark over a 3-year period with a return of 90.07% versus the Sensex's 39.71%. This indicates that although the stock is currently facing challenges, it has shown strong long-term performance relative to the broader market. The current liquidity status suggests that the stock remains liquid enough for trading, which may provide some stability amidst the recent price fluctuations.